your market intelligence analyst
Search Results
19 results
Your search is now limited to «Non-Hodgkin Lymphoma» expert search.
Your search is now limited to only one Source. To return to results from all sources click here. 09/04/2019 11:30
Condition : Lymphoma, Non-Hodgkin Interventions : Drug: RO7227166; Drug: Obinutuzumab; Drug: RO7082859 Sponsor : Hoffmann-La Roche Recruiting. 08/30/2019 08:52
Conditions : Recurrent Anaplastic Large Cell Lymphoma; Recurrent B-Cell Non-Hodgkin Lymphoma; Recurrent Classic Hodgkin Lymphoma; Recurrent Mycosis Fungoides; Recurrent Peripheral T-Cell Lymphoma; Refractory Anaplastic Large Cell Lymphoma; Refractory B-Cell Non-Hodgkin Lymphoma; Refractory Classic Hodgkin Lymphoma; Refractory Mycosis Fungoides; Refractory Peripheral T-Cell Lymphoma; TNFRSF8 Positive Interventions : Biological: Anti-CD30/CD16A Monoclonal Antibody AFM13; Drug: Cyclophosphamide; Drug: Fludarabine; Drug: Fludarabine Phosphate; Biological: Genetically Engineered Lymphocyte Therapy Sponsors : M.D. Anderson Cancer Center; National Cancer Institute (NCI) Not yet recruiting. 08/08/2019 08:43
Conditions : Lymphomas Non-Hodgkin's B-Cell; Diffuse Large B-cell Lymphoma (DLBCL); Primary Mediastinal B-cell Lymphoma (PMBCL); Transformed Follicular Lymphoma (TFL); Follicular Lymphoma (FL); Mantle Cell Lymphoma (MCL) Interventions : Biological: WZTL002-1 (1928T2z CAR-T cells); Drug: Cyclophosphamide and Fludarabine lymphodepleting chemotherapy Sponsors : Malaghan Institute of Medical Research; Wellington Zhaotai Therapies Limited Not yet recruiting. 07/23/2019 08:07
Conditions : CD19 Positive; CD22 Positive; Minimal Residual Disease; Progressive Disease; Recurrent B Acute Lymphoblastic Leukemia; Recurrent Chronic Lymphocytic Leukemia; Recurrent Non-Hodgkin Lymphoma; Refractory B Acute Lymphoblastic Leukemia; Refractory Chronic Lymphocytic Leukemia; Refractory Non-Hodgkin Lymphoma Interventions : Biological: Autologous CD19/CD22 Chimeric Antigen Receptor T-cells; Drug: Cyclophosphamide; Drug: Fludarabine Sponsors : M.D. Anderson Cancer Center; National Cancer Institute (NCI) Not yet recruiting. 07/23/2019 08:06
Conditions : Non-Hodgkin's Lymphoma, Relapsed; Chronic Lymphoid Leukemia in Relapse; Non-Hodgkin's Lymphoma Refractory; Chronic Lymphocytic Leukemia; Lymphoma, Non-Hodgkin; Leukemia, Lymphocytic, Chronic; B-cell Chronic Lymphocytic Leukemia; B-cell Non Hodgkin Lymphoma Interventions : Genetic: PBCAR20A; Drug: Fludarabine; Drug: Cyclophosphamide Sponsor : Precision BioSciences, Inc. Not yet recruiting.

Therapeutic Areas

Clinical Trials and Phases

Business Issues

Companies - Public

Companies - Venture Funded

Financial Results

Global Markets

Global Risk Factors

Government Agencies

Job Titles

Legal and Regulatory

Cell Receptors


Diagnostics and Therapeutics


Drugs - Brand Names

Drugs - Generic



Health Care

Health and Wellness

Human Anatomy

Mechanisms of Action

Medical Devices



Strategic Scenarios



On this page, you see the results of the search you have run.  You may also view the following:

  •  Click on this drop-down menu on the right hand side of the page, to choose between the machine learning-produced Insights Reports, or the listing of concepts extracted from the results, in chart or list format. 

  •  View the number of search results returned for the search in each of your collections, and click on any of those numbers to view the entire listing of results from the chosen collection.

  •  Use the search adjustment drop-downs to change the scope, sorting, and presentation of your results.

  •  Show or hide the record’s caption (content description).

  •  Show actions that can be made with the search result record.

  •  Click on the Save button after running your search, to save it so that its results will be updated each time relevant new content is added to the designated collection. You may choose to be notified via search alerts.

Click here for more info on Search Results

Click here for more info on Machine Learning applications